Trademark: 88681670
Status Date
Monday, November 27, 2023
Filing Date
Wednesday, November 6, 2019
Published for Opposition
Tuesday, September 1, 2020
Abandoned Date
Monday, November 27, 2023
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, including T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use
Nov 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 27, 2023
Abandonment - No Use Statement Filed
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Apr 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 13, 2023
Sou Extension 5 Granted
Apr 6, 2023
Sou Extension 5 Filed
Apr 13, 2023
Case Assigned To Intent To Use Paralegal
Apr 6, 2023
Sou Teas Extension Received
Oct 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 6, 2022
Sou Extension 4 Granted
Oct 6, 2022
Sou Extension 4 Filed
Oct 6, 2022
Sou Teas Extension Received
Apr 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 8, 2022
Sou Extension 3 Granted
Apr 8, 2022
Sou Extension 3 Filed
Apr 8, 2022
Sou Teas Extension Received
Oct 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2021
Sou Extension 2 Granted
Oct 25, 2021
Sou Extension 2 Filed
Oct 25, 2021
Sou Teas Extension Received
Apr 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2021
Sou Extension 1 Granted
Mar 30, 2021
Sou Extension 1 Filed
Mar 30, 2021
Sou Teas Extension Received
Oct 27, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 1, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 1, 2020
Published For Opposition
Aug 12, 2020
Notification Of Notice Of Publication E-Mailed
Jul 30, 2020
Approved For Pub - Principal Register
Jul 29, 2020
Teas/Email Correspondence Entered
Jul 28, 2020
Correspondence Received In Law Office
Jul 28, 2020
Teas Response To Office Action Received
Jan 29, 2020
Notification Of Non-Final Action E-Mailed
Jan 29, 2020
Non-Final Action E-Mailed
Jan 29, 2020
Non-Final Action Written
Jan 29, 2020
Assigned To Examiner
Nov 13, 2019
New Application Office Supplied Data Entered
Nov 9, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
